MYRIAD GENETICS INC. - COMMON STOCK

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium

09 дек 2024 15:05:00 Источник Nasdaq GlobeNewswire

NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'Advanced Tool' Recommended for Prognostic Assessment

09 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

06 дек 2024 08:53:52 Источник NetDania Notify

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

20 ноя 2024 15:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

20 ноя 2024 08:52:22 Источник NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

19 ноя 2024 09:20:58 Источник NetDania Notify

Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy

19 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

18 ноя 2024 08:46:05 Источник NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

15 ноя 2024 08:49:49 Источник NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

14 ноя 2024 08:54:04 Источник NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

13 ноя 2024 10:10:23 Источник NetDania Notify

Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch

13 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire

Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance

07 ноя 2024 15:05:02 Источник Nasdaq GlobeNewswire

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing

04 ноя 2024 07:39:37 Источник Nasdaq GlobeNewswire

Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024

30 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire

Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

16 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration

15 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer

08 окт 2024 15:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics

03 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

01 окт 2024 15:05:00 Источник Nasdaq GlobeNewswire